الصحة والعلوم الشرق الأوسط
World Health Organization reveals new findings about Ebola outbreak
5 Ways to Eat Bananas to Promote More Stable Blood Sugar Levels
Lupine: Rich Nutritional Value and Health Benefits
Does eating dates impact prostate inflammation?
Varicose veins: Why women are more affected and warning signs to watch for
المصدر: الصحة والعلوم الشرق الأوسط
14 Hrsجاهز للتشغيل
جاهز للتشغيل
The U.S. Food and Drug Administration has approved a new medication from Merck called "Lipfendra," which is used to significantly reduce bad cholesterol levels after traditional drugs like statins have failed to lower cholesterol in some patients. This medication is the first of its kind that works by inhibiting the "PCSK9" protein in the liver, thereby impairing the body's ability to eliminate cholesterol from the blood. The drug aims to improve cholesterol management, especially for patients with blocked arteries who struggle to achieve better levels with existing medications. Although drugs targeting the same protein have been available for over ten years, they have been limited due to high costs, insurance restrictions, and their infrequent prescription by doctors. The medication will be introduced to the market to enhance treatment options for individuals with high cholesterol.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading